Marktintelligenz

Denmark

Medizinprodukt-Marktintelligenz für Denmark. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.

52
Signals / 7 days
141
Activity Score
DKMA
EU MDR 2017/745 · CE Marking

Neueste Signale

reg_enforcement2026-05-08

A trial comparing AuraGain and I-gel for bronchoscopic intubation has been completed.

ClinicalTrials.gov · 2021-01-18
reg_enforcement2026-05-08

The pilot trial for the Hyposafe hypoglycaemia alarm device has been completed, demonstrating its safety and performance.

ClinicalTrials.gov · 2014-11-01
reg_enforcement2026-05-07

A study evaluated the treatment of humeral fractures using the Winsta PH device, sponsored by the University of Aarhus.

ClinicalTrials.gov · 2011-12-01
reg_enforcement2026-05-05

A completed study assessed a new ostomy device's performance in ileostomy patients using a measuring device.

ClinicalTrials.gov · 2018-02-05
reg_registration2026-05-05

Natus Medical Denmark ApS has registered with the FDA under product code LBI, listing one medical device.

FDA Device Registration & Listing ·
com_launch2026-05-04

The study evaluates the echoclip device's effectiveness in visualizing coronary anastomoses during bypass surgery.

ClinicalTrials.gov · 2016-09-01
reg_guidance2026-05-02

A study investigates the accuracy of continuous glucose monitoring versus standard blood glucose measurements in hospitalized diabetes patients.

ClinicalTrials.gov · 2024-04-01
reg_enforcement2026-04-30

The CLOSE-UP III Trial compares MynxGrip to manual compression for vascular closure after femoral access angiography.

ClinicalTrials.gov · 2014-06-16
mkt_report2026-04-30

A completed study examined how haptic devices affect proficiency and skill retention in laparoscopic simulators.

ClinicalTrials.gov · 2020-10-01
reg_enforcement2026-04-30

A completed trial compared blood levels of semaglutide using two injection devices, PDS290 and DV3372.

ClinicalTrials.gov · 2018-08-08
reg_enforcement2026-04-30

The pilot study evaluating the Hyposafe hypoglycaemia alarm device has been terminated.

ClinicalTrials.gov · 2010-11-01
Wettbewerber-Aktion2026-04-25

Medimaps Group and Radiobotics merge to enhance AI-driven musculoskeletal imaging solutions globally.

OrthoFeed · 2026-03-08
Wettbewerber-Aktion2026-04-24

Novo Nordisk aims to leverage consumer insights to enhance its US market strategy for Wegovy and Ozempic.

Financial Times Health · 2026-04-13
Markttrend2026-04-24

Novo Nordisk's Wegovy tablet aims to reclaim market share from Eli Lilly in the weight-loss medication sector.

Financial Times Pharmaceuticals · 2026-03-12
Regulatorische Änderung2026-04-24

The Dansac device by Dansac A/S is classified as Class I and registered with UDI-DI 05709817594355.

EUDAMED EU Device Database ·
Regulatorische Änderung2026-04-24

The Dansac device by Dansac A/S is classified as Class I and registered with UDI-DI 05709817518535.

EUDAMED EU Device Database ·
Regulatorische Änderung2026-04-24

The Dansac device by Dansac A/S is classified as Class I and registered with UDI-DI 05709817591163.

EUDAMED EU Device Database ·
Regulatorische Änderung2026-04-24

The Dansac device by Dansac A/S is classified as Class I and registered with UDI-DI 05709817604191.

EUDAMED EU Device Database ·
Regulatorische Änderung2026-04-24

The Dansac device by Dansac A/S is classified as Class I and registered with UDI-DI 05709817502541.

EUDAMED EU Device Database ·
Regulatorische Änderung2026-04-24

The Dansac device by Dansac A/S is classified as Class I and registered with UDI-DI 05709817604153.

EUDAMED EU Device Database ·

Ihre nächste Ausschreibung
ist am Freitag fällig.

Dreißig Minuten. Fünfzig Ihrer Positionen, live abgeglichen, gegen Ihre echte Ausschreibung.

Zugang anfordernMit einem Gründer sprechenDocs